Skip to main content

Table 4 Relative risk of second breast cancer vs. selected risk variables

From: Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis

Variable

RR (95% CI)

Mediastinal mass +

 

Wahner-Roedler 2003 [44]

4.22 (2.71, 6.57)

Alm El-Din 2009 [54]

11.46 (6.78, 19.38)

Mediastinal mass -

 

Wahner-Roedler 2003 [44]

1.70 (0.79, 3.63)

Alm El-Din 2009 [54]

6.09 (2.37, 15.67)

Splenectomy +

 

Wolden 1998 [30]

2.10 (0.62, 7.16)

Wahner-Roedler 2003 [44]

4.70 (2.87, 7.69)

Alm El-Din 2009 [54]

9.86 (5.42, 17.92)

Splenectomy -

 

Wahner-Roedler 2003 [44]

1.90 (1.05, 3.45)

Alm El-Din 2009 [54]

9.67 (4.87, 19.20)

Mantle RT, no pelvic RT

 

De Bruin 2009 [55]

8.20 (6.62, 10.15)

Mediastinal RT, no pelvic RT

 

De Bruin 2009 [55]

3.71 (1.38, 9.97)

Mantle RT + pelvic RT

 

De Bruin 2009 [55]

2.70 (1.11, 6.56)

ER-/PR-

 

Dores 2010 [57]

9.30 (7.00, 12.36)

ER+/PR+

 

Dores 2010 [57]

4.95 (3.84, 6.39)

  1. CI confidence interval, ER estrogen receptors, PR progesterone receptors, RR relative risk, RT radiotherapy.